Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The function of
BAD
, a proapoptotic member of the
Bcl-2
family, is regulated primarily by rapid changes in phosphorylation that modulate its protein-protein interactions and subcellular localization. We show here that, during interleukin-3 (IL-3) deprivation-induced apoptosis of 32Dcl3 murine myeloid precursor cells,
BAD
is cleaved by a caspase(s) at its N terminus to generate a 15-kDa truncated protein. The 15-kDa truncated
BAD
is a more potent inducer of apoptosis than the wild-type protein, whereas a mutant
BAD
resistant to caspase 3 cleavage is a weak apoptosis inducer. Truncated
BAD
is detectable only in the mitochondrial fraction, interacts with BCL-X(L) at least as effectively as the wild-type protein, and is more potent than wild-type
BAD
in inducing cytochrome c release. Human
BAD
, which is 43 amino acids shorter than its mouse counterpart, is also cleaved by a caspase(s) upon exposure of Jurkat T cells to anti-FAS antibody, tumor necrosis factor alpha (TNF-alpha), or TRAIL. Moreover, a truncated form of human
BAD
lacking the N-terminal 28 amino acids is more potent than wild-type
BAD
in inducing apoptosis. The generation of truncated
BAD
was blocked by
Bcl-2
in IL-3-deprived 32Dcl3 cells but not in Jurkat T cells exposed to anti-FAS antibody, TNF-alpha, or TRAIL. Together, these findings point to a novel and important role for
BAD
in maintaining the apoptotic phenotype in response to various apoptosis inducers.
...
PMID:Caspase cleavage enhances the apoptosis-inducing effects of BAD. 1128 8
Protein kinase C (PKC)-activating phorbol esters protect T cells from Fas-induced apoptosis. However, the mechanism of this protective effect and the identity of the relevant PKC isoform(s) are poorly understood. Here, we show that PKCtheta plays a selective and important role in this protection. Fas triggering led to a selective caspase-3-dependent cleavage of the enzyme and proteasome-mediated degradation and inactivation of its catalytic fragment. These events preceded the onset of apoptosis. Pharmacological inhibition of PKCtheta promoted Fas-mediated apoptosis in three different types of T cells. Conversely, constitutively active PKCtheta (and, to a lesser degree, PKCepsilon) selectively protected T cells from Fas-induced apoptosis. We provide evidence that the distant
Bcl-2
family member,
BAD
, is a PKCtheta substrate, is phosphorylated by TCR stimulation, and can mediate at least in part the anti-apoptotic effect of PKCtheta.
...
PMID:Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD. 1134 10
P11, a member of the S100 family of calcium-binding proteins, has been shown to interact with
BAD
(Bcl-xL/
Bcl-2
-associated death promoter) in the yeast two-hybrid protein-protein interaction assay. Because overexpression of P11 dampens the proapoptotic activity of
BAD
in transfected cells, we tested the possibility that the expression of this antiapoptotic protein may be regulated by gonadotropins and other survival factors in the ovary. Northern blot analysis of ovaries obtained from prepubertal rats revealed an increased expression of P11 messenger RNA (mRNA) during prepubertal development in the theca cells of preantral and early antral follicles. Treatment of immature rats with PMSG did not affect P11 expression, whereas treatment of PMSG-primed rats with an ovulatory dose of human (h)CG stimulated ovarian P11 mRNA within 6-9 h in the granulosa cells of preovulatory follicles. Treatment of cultured preovulatory follicles in vitro with LH further confirmed the time-dependent stimulation of P11 by gonadotropins. In addition, treatment of cultured preovulatory follicles with MDL-12,330A, an inhibitor of adenylate cyclase, inhibited LH-stimulated P11 mRNA, whereas treatment with forskolin, an adenylate cyclase activator, but not the protein kinase C activator, 2-O-tetradecanol-phorbal-13-acetate, mimicked the LH action, suggesting the role of adenylate cyclase activation in P11 expression. Treatment with other follicle survival factors, including the epidermal growth factor, the basic fibroblast growth factor, and interleukin-1beta, could also stimulate P11 expression in cultured preovulatory follicles. These results demonstrate the expression of P11 mRNA in theca cells of different-sized follicles and in granulosa cells of preovulatory follicles following gonadotropin stimulation, and suggest that P11 may mediate, at least partially, the survival action of gonadotropins during the ovulatory process.
...
PMID:Expression of messenger ribonucleic acid for the antiapoptosis gene P11 in the rat ovary: gonadotropin stimulation in granulosa cells of preovulatory follicles. 1135 77
Since the over-expression of
Bcl-2
is a common cause of multi-drug resistance, cytotoxic peptides that overcome the effects of
Bcl-2
may be clinically useful. We harnessed the death-promoting alpha helical properties of the BH3 domain of
BAD
by fusing it to the Antennapedia (ANT) domain, which allows for cell entry (ANTBH3BAD). Treatment of 32D cells with the ANTBH3BAD peptide results in a 99% inhibition of colony formation. No significant toxicity is observed after treatment with ANT or BH3BAD alone. A mutant fusion peptide unable to bind
Bcl-2
induces cell death as effectively as the wild-type ANTBH3BAD. Furthermore, 32D cells over-expressing
Bcl-2
show no resistance to the ANTBH3BAD peptide. Therefore, the toxicity of the peptide was independent of the
Bcl-2
pathway. We demonstrate that the toxicity of the peptide is due to its alpha helicity that disrupts mitochondrial function. Since this peptide overcomes major forms of drug resistance, it may be therapeutically useful if appropriately targeted to malignant cells.
...
PMID:The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2. 1146 17
Bcl-2
, an inner mitochondrial membrane protein, inhibits apoptotic neuronal cell death. Expression of
Bcl-2
inhibits cell death by decreasing the net cellular generation of reactive oxygen species. Studies by different investigators have provided unimpeachable evidence of a role for oxygen-based free radicals in methamphetamine (METH) -induced neurotoxicity. In addition, studies from our laboratory have shown that immortalized rat neuronal cells that overexpress
Bcl-2
are protected against METH-induced apoptosis in vitro. Moreover, the amphetamines can cause differential changes in the expression of Bcl-X splice variants in primary cortical cell cultures. These observations suggested that METH might also cause perturbations of
Bcl-2
-related genes when administered to rodents. Thus, the present study was conducted to determine whether the use of METH might indeed be associated with transcriptional and translational changes in the expression of
Bcl-2
-related genes in the mouse brain. Here we report that a toxic regimen of METH did cause significant increases in the pro-death
Bcl-2
family genes
BAD
, BAX, and BID. Concomitantly, there were significant decreases in the anti-death genes
Bcl-2
and Bcl-XL. These results thus support the notion that injections of toxic doses of METH trigger the activation of the programmed death pathway in the mammalian brain.
...
PMID:Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. 1148 Dec 22
Earlier studies have shown that the d120 mutant of herpes simplex virus 1, which lacks both copies of the alpha4 gene, induces apoptosis in all cell lines tested. In some cell lines d120-induced apoptosis, manifested by the release of cytochrome c, activation of caspase 3, and fragmentation of cellular DNA, is blocked by the overexpression of
Bcl-2
. In these cells viral protein kinase U(S)3 delivered in trans blocks apoptosis induced by the mutant virus at a premitochondrial stage. We report that the U(S)3 protein kinase targets the pro-apoptotic
BAD
member of the
Bcl-2
family. Specifically, the U(S)3 protein kinase mediates a posttranslational modification of
BAD
and blocks its cleavage, which is reported to activate apoptosis. Thus, U(S)3 protein kinase is the sole viral protein required to block activation of caspase 3, prevent cleavage of poly(ADP-ribose) polymerase, and block fragmentation of cellular DNA induced by
BAD
.
...
PMID:The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. 1151 26
Inhibitors of
Bcl-2
may be useful therapeutic agents for the treatment of a wide variety of malignancies including leukemia. A potential prototype of such a compound is the endogenous
Bcl-2
and Bcl-xL binding protein
BAD
. Previous reports indicate that
BAD
can overcome the anti-apoptotic effect of Bcl-xL but not
Bcl-2
. If
BAD
cannot induce apoptosis in cells over-expressing
Bcl-2
, it would limit the application of molecules like
BAD
as novel anti-tumor agents. We report that transient transfection of
BAD
induced cell death in cells with and without over-expression of
Bcl-2
or Bcl-xL. Forty-eight hours after transfection,
BAD
increased cell death in COS, COS
Bcl-2
, and COS Bcl-xL cells as demonstrated by decreased GFP expression, and an increase in the number of number of floating cells. In addition,
BAD
induced cell death in leukemic cell lines over-expressing
Bcl-2
and Bcl-xL as determined by changes in luciferase activity.
BAD
-induced apoptosis was not accompanied by loss of mitochondrial membrane potential. Therefore, we conclude that transient transfection of
BAD
directly induces apoptosis in cells over-expressing
Bcl-2
or Bcl-xL and validates the pursuit of molecules like
BAD
as novel therapeutic agents.
...
PMID:BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential. 1169 8
Transforming growth factor beta (TGF-beta) induces apoptosis in a variety of cells. We have previously shown that TGF-beta 1 rapidly induces apoptosis in the FaO rat hepatoma cell line. We have now studied the effect of TGF-beta 1 on the expression of different members of the
Bcl-2
family in these cells. We observed no detectable changes in the steady-state levels of
Bcl-2
, Bcl-X(L), and Bax. However, TGF-beta 1 induced caspase-dependent cleavage of
BAD
at its N terminus to generate a 15-kDa truncated protein. Overexpression of the 15-kDa truncated
BAD
protein enhanced TGF-beta 1-induced apoptosis, whereas a mutant
BAD
resistant to caspase 3 cleavage blocked TGF-beta 1-induced apoptosis. Overexpression of Smad3 dramatically enhanced TGF-beta 1-induced cleavage of
BAD
and apoptosis, whereas antisense Smad3 blocked TGF-beta 1-induced apoptosis and
BAD
cleavage. These results suggest that TGF-beta 1 induces apoptosis through the cleavage of
BAD
in a Smad3-dependent mechanism.
...
PMID:Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. 1183 4
Although ganciclovir (GCV) is most often used in suicide anticancer gene therapy, the mechanism of GCV-induced cell killing and apoptosis is not fully understood. We analysed the mechanism of apoptosis triggered by GCV using a model system of CHO cells stably transfected with HSV-1 thymidine kinase (HSVtk). GCV-induced apoptosis is due to incorporation of the drug into DNA resulting in replication-dependent formation of DNA double-strand breaks and, at later stages, S and G2/M arrest. GCV-provoked DNA instability was likely to be responsible for the observed initial decline in
Bcl-2
level and caspase-9/-3 activation. Further decline in the
Bcl-2
level was due to cleavage of the protein by caspase-9, as demonstrated by use of caspase inhibitors and transfection with trans-dominant negative caspase expression vectors.
Bcl-2
cleavage resulted in the appearance of a pro-apoptotic 23 kDa
Bcl-2
fragment and in excessive cytochrome c release, dephosphorylation of
BAD
, cleavage of PARP and finally DNA degradation. Since Fas/CD95 and caspase-8 were only slightly activated we conclude GCV-induced apoptosis to occur in this cell system mainly by activating the mitochondrial damage pathway. This process is independent of p53 for which the cells are mutated. Caspase-9 mediated cleavage of
Bcl-2
accelerates the apoptotic process and may explain the high potential of GCV to induce apoptosis. Data are also discussed as to implications for HSVtk gene therapy utilizing GCV.
...
PMID:Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. 1194 97
Calcium channel antagonists have been reported to have a favorable impact on cyclosporin A (CsA)-treated kidney transplant recipients. However, it is not clear whether this is because of their direct effect on antagonizing the toxicity of CsA to renal tubular cells. In this study, we have used Madin-Darby canine kidney tubular cells as a model to examine the effect of diltiazem, a calcium channel antagonist, on CsA-induced apoptosis. Moreover, to investigate the possible regulation of CsA cytotoxicity by intracellular calcium level, the effect of the calcium ionophore A23187 on CsA-induced apoptosis was also examined. We found that treatment of CsA (20 microM) alone caused 20-30% cell death, which was apparently (30-40%) enhanced by diltiazem at 100 microg/ml, accompanied by more severe DNA fragmentation, activation of caspases, and a decreased level of
Bcl-2
. The caspase inhibitor ZVAD-fmk or
Bcl-2
overexpression was capable of suppressing apoptosis induced by the synergistic effect of diltiazem and CsA. Moreover, the survival rate of cells treated with CsA (30 microM) alone remained only 30%, however, it was markedly (approximately 40%) elevated by co-treatment with A23187 (75 ng/ml). The rescue of cells from CsA-induced apoptosis by A23187 was correlated with AKT activation,
BAD
phosphorylation, and caspase-3 inactivation. Taken together, our results suggest that the reported favorable impact of diltiazem on kidney grafts is likely not because of its direct protection on renal tubular cells. Instead, it enhances the toxicity of CsA to renal tubular cells. In addition, our findings raise a possibility that the intracellular calcium level and the AKT pathway may participate in the regulation of CsA cytotoxicity.
...
PMID:Effect of calcium channel antagonist diltiazem and calcium ionophore A23187 on cyclosporine A-induced apoptosis of renal tubular cells. 1195 31
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>